My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
11-26-18_AGENDA PACKET
Clerk
>
Agenda Packets / Staff Reports
>
Planning Commission (2002-Present)
>
2018
>
11-26-2018
>
11-26-18_AGENDA PACKET
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/16/2019 2:22:53 PM
Creation date
8/16/2019 2:22:23 PM
Metadata
Fields
Template:
PBA
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
92
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br />5 <br /> <br />pollution.9 According to the updated guidance, quantified cancer risk should be multiplied by a factor of <br />ten during the third trimester of pregnancy and the first two years of life (infant) and should be <br />multiplied by a factor of three during the child stage of life (2 to 16 years). Furthermore, in accordance <br />with guidance set forth by OEHHA, we used 95th percentile breathing rates for infants.10 Finally, <br />according to SCAQMD guidance, we used a Fraction of Time At Home (FAH) Value of 1 for the 3rd <br />trimester, infant, and child receptors and we used a FAH Value of 0.73 for the adult receptors.11 We <br />used a cancer potency factor of 1.1 (mg/kg‐day)‐1 and an averaging time of 25,550 days. The results of <br />our calculations are shown below. <br /> <br />The Maximum Exposed Individual at an Existing Residential Receptor (MEIR) <br />Activity Duration <br />(years) <br />Concentration <br />(µg/m3) <br />Breathing Rate <br />(L/kg‐day) ASF Cancer Risk <br />Construction 0.25 0.4047 361 10 5.5E‐06 <br />3rd Trimester Duration 0.25 3rd Trimester Exposure 5.5E‐06 <br />Construction 1.22 0.4047 1090 10 8.1E‐05 <br />Operation 0.78 0.2534 1090 10 3.2E‐05 <br />Infant Exposure Duration 2.00 Infant Exposure 1.1E‐04 <br />Operation 14.00 0.2534 572 3 9.2E‐05 <br />Child Exposure Duration 14.00 Child Exposure 9.2E‐05 <br />Operation 14.00 0.2534 261 1 1.0E‐05 <br />Adult Exposure Duration 14.00 Adult Exposure 1.02E‐05 <br />Lifetime Exposure Duration 30.00 Lifetime Exposure 2.2E‐04 <br /> <br />As demonstrated above, the excess cancer risk to adults, children, infants, and 3rd trimester gestations <br />at a sensitive receptor located approximately 25 meters away, over the course of Project construction <br />and operation, are approximately 10, 92, 110, and 5.5 in one million, respectively. Furthermore, the <br />excess cancer risk over the course of a residential lifetime (30 years) is approximately 220 in one million. <br />Consistent with OEHHA guidance, exposure was assumed to begin in the 3rd trimester stage of <br />pregnancy to provide the most conservative estimates of air quality hazards. The infantile, child, adult, <br />and lifetime cancer risks all exceed the SCAQMD’s threshold of 10 in one million, thus resulting in a <br />potentially significant impact not previously addressed or identified by the DEIR or FEIR. <br /> <br />9 “Risk Assessment Guidelines Guidance Manual for Preparation of Health Risk Assessments.” OEHHA, February <br />2015, available at: https://oehha.ca.gov/media/downloads/crnr/2015guidancemanual.pdf <br />10 “Supplemental Guidelines for Preparing Risk Assessments for the Air Toxics ‘Hot Spots’ Information and <br />Assessment Act,” June 5, 2015, available at: http://www.aqmd.gov/docs/default‐source/planning/risk‐ <br />assessment/ab2588‐risk‐assessment‐guidelines.pdf?sfvrsn=6, p. 19 <br />“Risk Assessment Guidelines Guidance Manual for Preparation of Health Risk Assessments.” OEHHA, February <br />2015, available at: https://oehha.ca.gov/media/downloads/crnr/2015guidancemanual.pdf <br />11 “Risk Assessment Procedures for Rules 1401, 1401.1, and 212.” SCAQMD, August 2017, available at: <br />http://www.aqmd.gov/docs/default‐source/rule‐book/Proposed‐ <br />Rules/1401/riskassessmentprocedures_2017_080717.pdf, p. 7
The URL can be used to link to this page
Your browser does not support the video tag.